Casey C. Kopczynski
Net Worth
Last updated:
What is Casey C. Kopczynski net worth?
The estimated net worth of Dr. Casey C. Kopczynski is at least $12,580,071 as of 15 Feb 2021. He has earned $5,924,271 from insider trading and has received compensation worth at least $6,655,800 in Aerie Pharmaceuticals, Inc..
What is the salary of Casey C. Kopczynski?
Dr. Casey C. Kopczynski salary is $665,580 per year as Co-Founder & Chief Scientific Officer in Aerie Pharmaceuticals, Inc..
How old is Casey C. Kopczynski?
Dr. Casey C. Kopczynski is 64 years old, born in 1961.
What stocks does Casey C. Kopczynski currently own?
As insider, Dr. Casey C. Kopczynski owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Aerie Pharmaceuticals, Inc. (AERI) | Co-Founder & Chief Scientific Officer | 196,114 | $0 | $0 |
What does Aerie Pharmaceuticals, Inc. do?
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.
Casey C. Kopczynski insider trading
Aerie Pharmaceuticals, Inc.
Dr. Casey C. Kopczynski has made 12 insider trades between 2015-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 117,000 units of AERI stock on 3 Dec 2019. As of 15 Feb 2021 he still owns at least 196,114 units of AERI stock.
Aerie Pharmaceuticals key executives
Aerie Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Benjamin F. McGraw III, J.D., Pharm.D. (76) Executive Chairman
- Dr. Casey C. Kopczynski (64) Co-Founder & Chief Scientific Officer
- Dr. David A. Hollander M.B.A., M.D. (51) Chief R&D Officer
- Mr. John W. LaRocca Esq. (60) Gen. Counsel & Sec.
- Mr. Thomas A. Mitro (67) Pres & Chief Operating Officer